Santé
About Santé
Santé is a venture capital firm specializing in healthcare and technology, managing over $800 million in capital. Through Santé Ventures, the company invests in innovative early-stage companies in the Biotech, Medtech, and Healthtech sectors. Additionally, Santé Capital utilizes advanced machine learning techniques alongside expert investment strategies to achieve appealing risk-adjusted returns in public equities.
Recent News
Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment
Brado, Santé Ventures Partner to Transform Patient Navigation and Engagement
Graici Raises $7.5M in Series A Funding
Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology
AI Proteins Raises $41.5M in Series A Financing
E2 Raises $80M to Market Thrombectomy Platform
Recent Deals
Graici Secures $7.5M Series A Funding Led by Santé Ventures
AI Proteins Secures $41.5M Series A to Accelerate AI‑Driven Drug Discovery
Sonire Therapeutics Raises $18M Series A to Advance Pancreatic Cancer HIFU Therapy
Santé Secures $7.6M in Funding
E2 Raises $80M in Series C Funding to Advance Pulmonary Embolism Treatment
